Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis
Authors
Keywords
-
Journal
HYPERTENSION
Volume 78, Issue 3, Pages 629-643
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-06-21
DOI
10.1161/hypertensionaha.121.17049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
- (2020) Charles E. Evans et al. ACTA NEUROPATHOLOGICA
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment
- (2020) Ihab Hajjar et al. JAMA Network Open
- Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice
- (2020) Leah K. Cuddy et al. Science Translational Medicine
- Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions
- (2019) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study
- (2019) Christopher A Lane et al. LANCET NEUROLOGY
- The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?
- (2018) Patrick Gavin Kehoe JOURNAL OF ALZHEIMERS DISEASE
- Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology
- (2018) Zoe Arvanitakis et al. NEUROLOGY
- Cognitive benefits of angiotensin IV and angiotensin-(1–7): A systematic review of experimental studies
- (2018) Jean K. Ho et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies
- (2018) Salman Hussain et al. NEUROSCIENCE LETTERS
- Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study
- (2018) Sverre E. Kjeldsen et al. BLOOD PRESSURE
- Associations of Anti-Hypertensive Treatments with Alzheimer's Disease, Vascular Dementia, and Other Dementias
- (2018) Neil M. Davies et al. JOURNAL OF ALZHEIMERS DISEASE
- The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity
- (2018) Douglas Barthold et al. PLoS One
- Memory is preserved in older adults taking AT1 receptor blockers
- (2017) Jean K. Ho et al. Alzheimers Research & Therapy
- Introduction, comparison, and validation of Meta-Essentials : A free and simple tool for meta-analysis
- (2017) Robert Suurmond et al. Research Synthesis Methods
- Calcium-Channel Blockers and Dementia Risk in Older Adults – National Health Insurance Service – Senior Cohort (2002–2013) –
- (2016) Deri Hwang et al. CIRCULATION JOURNAL
- Intracerebroventricular Infusion of Angiotensin-(1–7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer’s Disease
- (2016) Ken Uekawa et al. JOURNAL OF ALZHEIMERS DISEASE
- Diuretic antihypertensive drugs and incident dementia risk
- (2016) Phillip J. Tully et al. JOURNAL OF HYPERTENSION
- Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
- (2016) Patrick Gavin Kehoe et al. Alzheimers Research & Therapy
- Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
- (2015) Sarah R. Gillett et al. CLINICAL NEUROPSYCHOLOGIST
- Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis
- (2015) R. Ye et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease
- (2015) Whitney Wharton et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production
- (2015) Mark A. Lovell et al. Oxidative Medicine and Cellular Longevity
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion
- (2014) Wei Xie et al. BRAIN RESEARCH
- A Neurodegenerative Vascular Burden Index and the Impact on Cognition
- (2014) Sebastian Heinzel et al. Frontiers in Aging Neuroscience
- Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial
- (2013) Nobuyuki Sato et al. JOURNAL OF HYPERTENSION
- Antihypertensive classes, cognitive decline and incidence of dementia
- (2013) Natacha Levi Marpillat et al. JOURNAL OF HYPERTENSION
- Optimal Blood Pressure for Cognitive Function: Findings from an Elderly African-American Cohort Study
- (2013) Hai Liu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
- (2013) Rebecca M. Turner et al. PLoS One
- A Comparison of Cognitive and Everyday Functional Performance Among Older Adults With and Without Hypertension
- (2013) Elizabeth M. Hudak et al. Clinical Gerontologist
- Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series
- (2012) Ihab Hajjar et al. ARCHIVES OF NEUROLOGY
- Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging
- (2011) Vincenzo Solfrizzi et al. AGE
- Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
- (2011) Berislav V. Zlokovic NATURE REVIEWS NEUROSCIENCE
- Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
- (2010) Craig Anderson et al. LANCET NEUROLOGY
- Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
- (2010) Julius Benicky et al. NEUROPSYCHOPHARMACOLOGY
- Hypertension, cognitive decline and dementia
- (2009) E. Duron et al. Archives of Cardiovascular Diseases
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension
- (2009) Kaycee M. Sink et al. ARCHIVES OF INTERNAL MEDICINE
- Promising Strategies for the Prevention of Dementia
- (2009) Laura E. Middleton et al. ARCHIVES OF NEUROLOGY
- Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
- (2009) Albert Fournier et al. Expert Review of Neurotherapeutics
- Duration of antihypertensive drug use and risk of dementia: A prospective cohort study
- (2009) M.D.M. Haag et al. NEUROLOGY
- Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons
- (2009) L. B. Hoffman et al. NEUROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Angiotensin-converting enzyme 2 in the brain: properties and future directions
- (2008) Huijing Xia et al. JOURNAL OF NEUROCHEMISTRY
- Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention
- (2008) Fatima-Zohra Kettani et al. STROKE
- The MOBILIZE Boston Study: Design and methods of a prospective cohort study of novel risk factors for falls in an older population
- (2008) Suzanne G Leveille et al. BMC Geriatrics
- Use of calcium antagonists and cognitive decline in old age
- (2006) Stella Trompet et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search